Boylan James P 4
4 · Zenas BioPharma, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Boylan James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+18,500→ 18,500 totalExercise: $11.94Exp: 2035-06-10→ Common Stock (18,500 underlying)
Footnotes (2)
- [F1]The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service.
- [F2]The reporting person holds the stock option, and the shares underlying the option, for the benefit of Enavate Sciences, LP. Accordingly, the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, if any.